Related by context. All words. (Click for frequent words.) 78 sirolimus eluting stents 77 everolimus eluting stents 74 TAXUS Express Stent 74 reinfarction 74 XIENCE V demonstrated 73 β blockers 72 Taxus Stent 72 CYPHER R Sirolimus eluting 71 TAXUS Liberte Stent 71 dosage regimens 71 multivessel disease 70 Cypher Stent 70 carotid endarterectomy CEA 70 angiographic outcomes 70 antiarrhythmic drug 70 nondiabetic patients 70 antiplatelet drugs 70 Doxil ® 70 CYPHER Stent 70 NPH insulin 70 DAPT 70 NEVO ™ 70 sirolimus eluting 70 recurrent GBM 69 XIENCE V stent 69 XIENCE V PROMUS Stent 69 IOP lowering 69 sirolimus eluting stent 69 oncologic outcomes 69 revascularization procedures 69 left ventricular dysfunction 69 carotid artery stenting 69 transfemoral 69 colorectal liver metastases 69 pCR 69 everolimus eluting stent 68 dalteparin 68 carotid artery stenting CAS 68 TAXUS Stent 68 chemoembolization 68 pegylated liposomal doxorubicin 68 binary restenosis 68 paclitaxel eluting stent 68 angiographic restenosis 68 mm Stent 68 radical nephrectomy 68 ATACAND 68 periprocedural 68 bivalirudin 68 CYPHER ® 68 abacavir lamivudine 68 unfractionated heparin 68 lipid lowering agents 68 revascularizations 68 intravesical therapy 68 CYPHER ® Stent 67 KRAS mutations occur 67 carotid revascularization 67 mycophenolate mofetil 67 thrombus aspiration 67 androgen suppression 67 zotarolimus eluting stent 67 fluvastatin 67 EURIDIS 67 coronary stenting 67 patients undergoing CABG 67 Genous stent 67 stent implantation 67 GP IIb IIIa inhibitors 67 conventional angiography 67 MACCE 67 postoperative mortality 67 preoperative chemotherapy 67 renal tumors 67 coronary revascularization 67 locoregional recurrence 67 ARB telmisartan 67 nephron sparing surgery 67 repeat revascularization 67 flutamide 67 serum calcium levels 67 oral rivaroxaban 67 carotid stenting 67 fibrinolytic therapy 67 elective PCI 67 deep venous thromboses 67 VELCADE melphalan 67 RE LY ® 67 radial artery grafts 67 tirofiban 67 CYPHER R Stent 66 reintervention 66 morphometric vertebral fractures 66 symptomatic VTE 66 eptifibatide 66 postintervention 66 intravenous bisphosphonates 66 FOLFOX4 66 paroxysmal AF 66 antiangiogenic therapy 66 thromboembolic events 66 tolvaptan 66 ARCOXIA 66 salmeterol fluticasone 66 GnRH agonists 66 Prospective Randomized Trial 66 hemodynamically significant 66 Events MACE 66 insulin detemir 66 aldosterone antagonists 66 undergoing coronary artery 66 radiochemotherapy 66 primary patency 66 irbesartan 66 iodixanol 66 coronary interventions 66 thromboprophylaxis 66 strontium ranelate 66 ischemic cardiomyopathy 66 endarterectomy 66 unfractionated heparin UFH 66 dual antiplatelet therapy 66 active comparator 66 transthoracic 66 metastatic neuroendocrine tumors 66 HIV HCV coinfected 66 antithrombotic therapy 66 aspirin clopidogrel 66 OPCAB 66 PSA nadir 66 androgen deprivation 66 definite stent thrombosis 66 MGd 66 pamidronate 66 zotarolimus 66 oral antidiabetic medication 66 dose atorvastatin 66 clodronate 66 intravitreal injections 66 clopidogrel Plavix 66 cilostazol 66 sirolimus stent 66 rosuvastatin #mg 66 lipid lowering therapy 66 unresectable tumors 66 atorvastatin #mg 66 gemcitabine Gemzar 66 rFVIIa 66 adjuvant radiotherapy 66 hepatic metastases 66 subgroup analyzes 66 HORIZONS AMI trial 66 octreotide LAR 66 beta blocker therapy 66 teriflunomide 66 TAXUS TM 66 perioperative morbidity 66 symptomatic carotid stenosis 66 relapsed MM 66 neoadjuvant 66 Val HeFT 66 colorectal adenoma 66 LV dysfunction 66 SYNTAX trial 66 antiarrhythmic drugs 66 noninferior 66 riociguat 66 leiomyomas 66 liver resection 66 daily subcutaneous injections 66 placebo controlled clinical 66 concurrent chemoradiation 66 stent DES 66 angioplasty stenting 65 interferon alfa 2b 65 IFN beta 65 intracoronary 65 recurrent glioblastoma multiforme 65 lanthanum carbonate 65 liver metastasis 65 unstable angina pectoris 65 T2DM 65 underwent resection 65 MitraClip device 65 CTAP# Capsules 65 unstable angina UA 65 Fulvestrant 65 prospectively stratified 65 ipsilateral stroke 65 ACUITY trial 65 APTIVUS r 65 CIMZIA ™ 65 drug eluting stent implantation 65 PSADT 65 nonrandomized 65 aldosterone antagonist 65 HoLEP 65 pain palliation 65 docetaxel Taxotere ® 65 ablative therapy 65 hepatic resection 65 sorafenib Nexavar 65 Combo Stent 65 perioperative complications 65 perioperative mortality 65 MIRAPEX 65 postoperative chemotherapy 65 paricalcitol 65 LMWH 65 ischemia driven 65 candidemia 65 antiplatelet medications 65 oral diclofenac 65 PNH patients 65 nonoperative treatment 65 intravenous dosing 65 ARIXTRA 65 carotid stenosis 65 intracranial stenosis 65 NAVISTAR R 65 hsCRP levels 65 patients undergoing percutaneous 65 arterial grafts 65 drug eluting stent DES 65 stenoses 65 adrenalectomy 65 nadolol 65 skeletal metastases 65 recurrent VTE 65 certolizumab 65 Bivalirudin 65 advanced adenomas 65 analgesic efficacy 65 Platinol ® cisplatin 65 mg administered orally 65 hyperphenylalaninemia HPA due 65 postoperative morbidity 65 TAXUS stent 65 antihypertensive therapy 65 nicardipine 65 ritonavir boosted 65 Acute Ischemic Stroke 65 CYPHER R Sirolimus Eluting 65 LNG IUS 65 saphenous vein grafts 65 trabeculectomy 65 metastatic castration resistant 65 dacarbazine 65 carboplatin paclitaxel 65 ejection fractions 65 methotrexate monotherapy 65 NATRECOR ® 65 TAXUS Liberte Long 65 chlorambucil 65 EBRT 65 ximelagatran 65 fallopian tube cancers 65 neointimal 65 thromboembolic 65 cytoreductive surgery 65 AGILECT R 65 valve implantation 65 intravenous cyclophosphamide 65 target lesion revascularization 65 revascularization 65 paclitaxel stent 65 stable angina 65 chemoradiation therapy 65 β blocker 65 TNF antagonist 65 CABG surgeries 65 VADT 65 CaPre TM 65 perioperatively 65 asymptomatic carotid stenosis 65 CIMZIA TM certolizumab pegol 65 NEVO 65 thienopyridines 65 hemostatic efficacy 65 adjuvant radiation 65 Percutaneous Coronary Intervention 65 prostate TURP 65 micafungin 65 acute STEMI 65 DES implantation 65 biochemical recurrence 64 Coronary Artery Bypass Graft 64 nonischemic 64 lispro 64 TEAEs 64 candesartan cilexetil 64 fosamprenavir 64 tenofovir emtricitabine 64 levosimendan 64 Losartan 64 relapsed ALL 64 FIRMAGON 64 thrombolytics 64 CRESTOR #mg 64 percutaneous intervention 64 carotid endarterectomy 64 FOLFIRI 64 coronary lesions 64 Heparin Bioactive Surface 64 lenalidomide dexamethasone 64 tumor resection 64 TAVR 64 oral FTY# 64 thienopyridine 64 transurethral resection 64 alfuzosin 64 adjuvant tamoxifen 64 doxorubicin docetaxel 64 trials RCTs 64 deferiprone 64 melphalan prednisone 64 cystectomy 64 alteplase 64 transcatheter closure 64 allogeneic HSCT 64 antiplatelet agent 64 antiangiogenic agents 64 Bare Metal Stents 64 atherothrombotic events 64 CC genotype 64 revascularized 64 deferoxamine 64 Stenting 64 Tavocept 64 FASLODEX 64 endobronchial 64 NSTE ACS 64 neointimal hyperplasia 64 elevated LDH 64 decitabine 64 INCB# [003] 64 calcineurin inhibitors 64 dose dexamethasone 64 ketorolac 64 VATS lobectomy 64 lenalidomide Revlimid R 64 thromboembolic complications 64 PROMUS 64 antiplatelet therapy 64 gefitinib Iressa 64 PROMUS Element Stent 64 Resolute DES 64 lung resection 64 Coronary Stent 64 systemic embolism 64 undetectable HBV DNA 64 titrated glipizide 64 neurologic outcomes 64 trabectedin 64 tenecteplase 64 ACE inhibitor ramipril 64 TACE 64 mTOR inhibitors 64 ibandronate 64 pyridostigmine 64 ExTRACT TIMI 64 fosbretabulin 64 Kaplan Meier analysis 64 platelet reactivity 64 SYNERGY Stent 64 autologous chondrocyte implantation 64 SPIRIT FIRST 64 EDARBI 64 oral anticoagulation 64 NATRECOR R 64 Fondaparinux 64 subtrochanteric 64 basal bolus regimen 64 SORT OUT III 64 fondaparinux 64 prasugrel Effient 64 T1DM 64 imipenem 64 endometrial hyperplasia 64 Thalomid ® 64 debulking surgery 64 thoracoscopic lobectomy 64 myocardial infarction MI 64 stent restenosis 64 doxorubicin cyclophosphamide 64 azacitidine 64 extracranial 64 rt PA 64 #.#mg/dL 64 tamsulosin 64 BENICAR HCT 64 FDG-PET/CT 64 nebulization 64 ACCORD Lipid 64 recurrent malignant glioma 64 tipranavir r 64 treated nonsurgically 64 metaglidasen 64 radiotherapy RT 64 5-FU/LV 64 Carvedilol 64 revascularization procedure 64 RELIANT Trial 64 standard chemotherapy regimens 64 nonobstructive CAD 64 latanoprost 64 Atom Stent 64 Protelos 64 tacrolimus ointment 64 estramustine 64 anti arrhythmic drug 64 Erythropoietic therapies may 64 uncoated stent 64 rebleeding 64 postoperative AF 64 standard chemotherapy regimen 64 prednisone prednisolone 64 nonfatal MI 64 Flu Cy 64 adjuvant therapies 64 Edwards SAPIEN valve 64 recurrent myocardial infarction 64 sunitinib Sutent 63 reperfusion therapy 63 ARIMIDEX 63 lipid lowering drugs 63 penetrating keratoplasty 63 tolterodine ER 63 Xelox 63 caspofungin 63 axillary node dissection 63 intravenous diuretics 63 CABG coronary artery 63 Long Lesion 63 paclitaxel cisplatin 63 Pegylated Liposomal Doxorubicin 63 antimicrobial prophylaxis 63 multicenter trials 63 lymphadenectomy 63 neoadjuvant therapy 63 drug eluting coronary stents 63 bolus dose 63 fluticasone salmeterol 63 urodynamic 63 VTE prophylaxis 63 metastatic RCC 63 goserelin 63 metastatic HRPC 63 complete cytogenetic response 63 MERLIN TIMI 63 evaluating tivozanib 63 sirolimus 63 inhaled budesonide 63 TAXUS VI 63 Acute Myocardial Infarction 63 thrombolytic therapy 63 PRADAXA #mg 63 biliary tract cancer 63 pimecrolimus 63 LHRH agonists 63 INTEGRILIN R 63 methotrexate therapy 63 thalidomide Thalomid 63 occlusive disease 63 carotid IMT 63 vinorelbine 63 cinacalcet 63 thrombolytic agents 63 fibrinolysis 63 Dabigatran 63 FUSILEV enhances 63 atrioventricular block 63 circulating EPCs 63 resynchronization therapy 63 Target Lesion Revascularization TLR 63 percutaneous transluminal coronary angioplasty 63 Ranolazine 63 Ophena 63 pretransplant 63 salmeterol HFA MDI 63 adenoidectomy 63 bivalirudin alone 63 insulin lispro 63 weekly subcutaneous injections 63 CALGB # [002] 63 invasive candidiasis 63 ACTEMRA TM 63 TAXUS Express2 63 ablation procedures 63 virological response 63 canakinumab 63 pharmacodynamic properties 63 SCIg 63 idraparinux 63 Combination therapy 63 idarubicin 63 onset atrial fibrillation 63 underwent surgical resection 63 phakic 63 STRIDE PD 63 catheter occlusion 63 demonstrated antitumor activity 63 prostate carcinoma 63 zoledronate 63 oxcarbazepine 63 liposomal doxorubicin 63 EDEMA3 trial 63 prospectively defined 63 antithrombotic therapies 63 antihypertensive drugs 63 steroid dexamethasone 63 sleeve lobectomy 63 interferon ribavirin 63 demonstrated clinically meaningful 63 Perforomist Inhalation Solution 63 Endarterectomy 63 de novo lesions 63 lipid lowering medications 63 colorectal adenomas 63 hemorrhagic complications 63 antiandrogens 63 carotid artery stenosis 63 photocoagulation 63 Procoralan 63 cardiac repolarization 63 ticagrelor 63 sunitinib malate 63 RSD# oral 63 elevated troponin 63 percutaneous interventions 63 Stent thrombosis 63 null responder 63 bypass grafting 63 tolterodine 63 hemodialysis patients 63 revascularisation 63 #beta estradiol 63 Nilotinib 63 graft occlusion 63 non valvular atrial 63 Elitek 63 abciximab 63 Patency 63 ribavirin USP 63 Natalizumab 63 cranial irradiation 63 Epanova 63 chlorthalidone 63 periprocedural MI 63 Thal Dex 63 bioabsorbable stent 63 interferon alfa 2a 63 oxaliplatin Eloxatin 63 bosentan 63 renal dysfunction 63 PLX STROKE targeting 63 XELOX 63 LT NS# 63 recurrent metastatic 63 transcatheter aortic valve implantation 63 platelet inhibitor 63 IFN alfa 63 antiretroviral naive 63 serum creatinine levels 63 Xanafide 63 FOSRENOL ® 63 anticoagulant warfarin 63 antithrombotics 63 retinal vein occlusion 63 MADIT II 63 pioglitazone Actos 63 IM progesterone 63 serum urate 63 stage IIIb IV 63 heavily pretreated 63 administered subcutaneously 63 upper gastrointestinal bleeding 63 #mg BID [001] 63 HBeAg seroconversion 63 Angiox R 63 venous thromboembolic disease 63 anticlotting drugs 63 briakinumab 63 bendamustine 63 prospective multicenter study 63 bexarotene 63 HCV RESPOND 2 63 biochemical relapse 63 salpingo oophorectomy 63 plus dexamethasone 63 carotid stents 63 typical antipsychotics 63 GORE VIABAHN Endoprosthesis 63 carotid artery blockage 63 silent ischemia 63 venlafaxine Effexor 63 REYATAZ r arm 63 CYPHER ® Sirolimus eluting 63 cisplatin chemotherapy 63 symptomatic intracranial 63 nab paclitaxel 63 AZT zidovudine Retrovir 63 FOLPI 63 metformin sulfonylurea 63 Myocardial Infarction Study 63 eplerenone 63 coadministration 63 infarct size 63 resected pancreatic cancer 63 TAXUS stents 63 VAPRISOL 63 glargine 63 mcg albinterferon alfa 2b 63 primary percutaneous coronary 63 uricase 63 CR nPR 63 lopinavir r arm 63 antithrombotic 63 undergone radical prostatectomy 63 comparator arm 63 tapentadol ER 63 infective endocarditis 63 bicalutamide 63 hepatectomy 63 Ventavis ® 63 incomplete revascularization 63 dosing cohorts 63 transdermal estrogen 63 hypervascular 63 tamoxifen Nolvadex ® 63 thrombogenic 63 artery stenosis 62 angiotensin converting enzyme inhibitors 62 gadobutrol 62 ZOLINZA 62 serum phosphorous 62 dosing frequency 62 Octreolin 62 antiandrogen 62 Capecitabine 62 ENDEAVOR III 62 transplantation HCT 62 evaluable subjects 62 defibrillator CRT D 62 endocrine therapies 62 SPIRIT III 62 #mg doses [002] 62 arterial revascularization 62 acromegalic patients 62 plus prednisone 62 eluting stent 62 pioglitazone HCl 62 Tarceva TM 62 oral anticoagulant therapy 62 clinically localized prostate 62 inhaled anticholinergics 62 Tamibarotene 62 superficial femoral 62 platelet inhibition 62 thrombotic events 62 omecamtiv mecarbil 62 TURBT 62 rosuvastatin Crestor 62 PASI scores 62 Cloretazine 62 anti angiogenic agents 62 adenomatous 62 surgical revascularization 62 malignant neoplasms 62 immunomodulatory therapy 62 refractory ischemia 62 TELINTRA 62 ICD implantation 62 MAGE A3 ASCI 62 TAXUS Express Atom Stent 62 bezafibrate 62 recurrent ischemia 62 IIIa inhibitor 62 coronary revascularization procedures 62 cardiac resynchronisation therapy 62 PICSO ® 62 DU #b 62 antidiabetic drugs 62 immunosuppressive agents 62 pneumonectomy 62 EVIZON 62 coronary blockages 62 parathyroidectomy 62 ACEIs 62 CANCIDAS 62 myocardial infarction stroke 62 monophasic 62 TAXUS ® 62 diuretic chlorthalidone 62 delafloxacin 62 nephrectomy 62 oral anticoagulants 62 adenomatous polyps 62 coronary stenoses 62 Endeavor stent 62 oxycodone IR 62 liposomal amphotericin B 62 underwent CABG 62 solifenacin 62 Edge STudy 62 dacarbazine chemotherapy 62 placebo dexamethasone 62 direct thrombin inhibitors 62 percutaneous cryoablation 62 preventing restenosis 62 Telmisartan 62 CYT# potent vascular disrupting 62 pharmacokinetic characteristics 62 ß blockers 62 CRT ICD 62 preintervention 62 pan HDAC inhibitor 62 Femara letrozole 62 TAXUS Express 62 endoleaks 62 prucalopride 62 stents BMS 62 antiangiogenic agent 62 pancreatic adenocarcinoma 62 nephrectomies 62 ancrod 62 Ophena TM 62 undergoing CABG 62 severe neutropenia 62 non squamous NSCLC 62 Sirolimus 62 taxane therapy 62 adenoma recurrence 62 troponin T 62 ticlopidine 62 renal insufficiency 62 Randomized Evaluation 62 Diabetic Macular Edema 62 K ras mutations 62 LHRH receptor positive 62 tumor excision 62 postmenopausal osteoporotic women 62 coronary intervention 62 MoxDuo TM IR 62 glycoprotein IIb IIIa inhibitors 62 Pemetrexed 62 uncoated stents 62 reoperations 62 Advagraf 62 sinus rhythm 62 metabolic parameters 62 radical cystectomy 62 carvedilol 62 #mg/day [001] 62 subcutaneous enoxaparin 62 IFN α 62 FFR guided treatment 62 simvastatin ezetimibe 62 relapsing remitting MS RRMS 62 paclitaxel eluting 62 diameter stenosis 62 eosinophil count 62 4mg/kg 62 CA4P 62 subclinical hypothyroidism 62 workhorse lesions 62 Stent System 62 ribavirin RBV 62 Adjuvant chemotherapy 62 secondary efficacy endpoint 62 visceral metastases 62 achieved CCyR 62 external beam radiotherapy 62 TAXUS Liberté stent 62 Raptiva r 62 Randomized Clinical Trial 62 cerebrovascular events 62 amoxicillin clavulanate 62 renal cell carcinomas 62 transarterial chemoembolization 62 biphasic insulin aspart 62 myocardial reperfusion 62 Fludara 62 Apidra ® 62 prostate cancer CaP 62 PPAR gamma agonists 62 Radical prostatectomy 62 NMIBC 62 thrombocytopenic 62 stenting 62 thromboembolism 62 renal artery stenosis 62 carcinoids 62 Abciximab 62 Surgical resection 62 WallFlex Biliary RX 62 HIF PH inhibitors 62 nonoperative 62 ADHF 62 CARE HF 62 cisplatin vinorelbine 62 benazepril 62 dose Iluvien 62 intravitreal injection 62 low dose cytarabine 62 omega interferon 62 chemotherapy gemcitabine 62 FOSRENOL R 62 darunavir r 62 serum phosphate 62 APTIVUS R 62 TURP 62 INVEGA ® 62 EFFEXOR XR 62 HMG CoA reductase inhibitors 62 severe aortic stenosis 62 HER2 expression 62 TAXUS Element Stent 62 aspirin heparin 62 Vidaza ® 62 PegIFN RBV 62 paroxysmal atrial fibrillation 62 Insulin detemir 62 induce orthostatic hypotension 62 Restenosis 62 endovascular repair 62 fundoplication 62 pharmacologically active isomer 62 sipuleucel T 62 corrected QT interval 62 surrogate endpoint 62 pharmacokinetic interactions 62 intracranial hemorrhage ICH 62 receiving VELCADE 62 severe renal impairment 62 ORENCIA R 62 transapical 62 coronary anatomy 62 transarterial 62 GORE TAG Device 62 Adjunctive 62 contralateral breast 62 statistically significant efficacy 62 dose statin therapy 62 antibiotic prophylaxis 62 carotid angioplasty 62 intravascular hemolysis 62 ARCALYST ® 62 therapeutic regimens 62 valsartan 62 pravastatin therapy 62 recurrent NSCLC 62 #mg dose [001] 62 macrovascular disease 62 Phase IIIb clinical 62 Unfractionated Heparin 62 interferon gamma 1b 62 otamixaban 62 carotid plaque 62 mRCC 62 serum concentrations 62 Erlotinib 62 dronedarone 62 amifostine 62 docetaxel chemotherapy 62 parous women 62 medically inoperable 62 OAB symptoms 62 cytotoxic therapy 62 ceftazidime 62 nonfatal myocardial infarction 62 PTNS 62 Sirolimus eluting 62 PFO closure 62 Hepatocellular Carcinoma HCC 62 infarctions 62 coronary artery bypass grafts 62 NNRTI resistance 62 statistically significant p = 62 HoFH 62 NYHA Class II 62 corticosteroid dose 62 angiotensin receptor blocker ARB 62 Microplasmin 62 Temsirolimus 62 oxymorphone ER 62 composite endpoint 62 inhaled glucocorticoids 62 refractory angina 62 CYP#D# inhibitor 62 colorectal neoplasms 62 dapagliflozin plus 62 palifermin 62 percutaneous biopsy 62 rtPA 62 vorinostat 62 STARFlex R 62 pegfilgrastim 62 intima media thickness 62 tibolone 62 DMARD 62 RoACTEMRA 62 Hypotension 62 conventional coronary angiography 62 ALND 62 enalapril 62 inhaled corticosteroid therapy 62 posterolateral fusion 62 locoregional 62 PERSEUS clinical program 62 prospective randomized controlled 62 Vidaza azacitidine 62 ABSORB trial 62 Sirolimus eluting Coronary Stent 62 Endometrial 62 pulmonary artery banding 62 chronic hemodialysis 62 Paraplatin ® 62 mg QD 62 metastatic GIST 62 nebulized formoterol fumarate 62 PREZISTA r 61 VIRAMUNE 61 hemoglobin A1c levels 61 ULORIC 61 neurologic progression 61 mcg QD 61 Meets Primary Endpoint 61 risperidone Risperdal 61 events MACE 61 Sumatriptan OS 61 efficacy evaluable 61 F FDG PET 61 mg kg dose 61 #mg dose [003] 61 receiving prophylactic anticoagulation 61 percutaneous coronary interventions 61 Lenalidomide 61 eculizumab therapy 61 zafirlukast 61 ularitide 61 saline placebo 61 galiximab 61 fallopian tube carcinoma 61 xenograft models 61 dose clopidogrel 61 HCV SPRINT 61 papillary renal cell carcinoma 61 PEGINTRON TM 61 SLNB 61 bifurcated lesions 61 macrovascular events 61 peri procedural 61 undergoing coronary angiography 61 thyrotropin levels 61 oral prednisolone 61 luminal diameter 61 Keppra XR 61 microvascular disease 61 Atypical Hemolytic Uremic Syndrome 61 induced macular edema 61 adjunctive placebo 61 hypogonadal men 61 thiazide diuretic 61 intraoperative complications 61 nonmetastatic prostate cancer 61 adult chronic ITP 61 epithelial tumors 61 proliferative retinopathy 61 VESTAsync 61 serum phosphate levels 61 drug zotarolimus 61 postoperative complication 61 HGPIN 61 myocardial revascularization 61 epoetin alpha 61 dexamethasone Decadron 61 VDAs 61 rosuvastatin 61 angiotensin II receptor blockers 61 Cotavance 61 5-fluorouracil/leucovorin 61 mycophenolic acid 61 dipyridamole plus 61 Angiographic 61 relapsed ovarian cancer 61 cardiac perfusion 61 cobiprostone 61 chest radiographs 61 vertebral fracture 61 Diovan HCT 61 gadolinium enhanced 61 response CCyR 61 follicular lymphomas 61 dosing cohort 61 ventricular tachyarrhythmia 61 Coronary artery bypass graft 61 MIST II 61 renal cortical